Catalyst Wire Dossier Catalyst Wire Dossier

Agenerase

amprenavir · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Agenerase, covering 2008-04-01 to 2014-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults [Phase 1]

See pricing